Cost-effectiveness analysis of nintedanib esylate in the treatment of idiopathic pulmonary fibrosis
HU Jiahao, LIU Yuhan, PAN Xingming, JIN Chunlin, LI Fen
Cost-effectiveness analysis of nintedanib esylate in the treatment of idiopathic pulmonary fibrosis
{{custom_ref.label}} |
{{custom_citation.content}}
{{custom_citation.annotation}}
|
/
〈 | 〉 |